CSF3 and cerebrotendinous xanthomatosis: On days 10 and 14, the chemotactic ability in the G-CSF group was lower than that in the control and APS groups (P = 0.028 on day 10 and P = 0.017 on day 14 vs. control group; P = 0.001 on day 10 and P = 0.005 on day 14 vs. APS group), and mature BM granulocytes and peripheral blood PMNLs in the APS group showed significant improvements in such capabilities after 7 days relative to those in the CTX group (Fig. 5).